company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10304000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10304000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10304000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1602000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6456000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8058000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2246000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,36000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2282000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,535000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1747000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32780000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33084000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 06:02:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10724000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1268000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5460000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6728000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3996000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4023000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-525000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4548000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4548000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4548000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32789000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:47:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10432000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10432000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10417000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1696000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4711000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6407000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4010000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4039000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4039000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4039000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4039000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32807000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33113000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33700000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:03:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10354000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10354000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10299000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3280000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5209000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8489000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1810000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1835000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1792000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,0.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32821000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33134000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 06:02:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10573000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10573000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,139000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,139000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10434000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1429000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5018000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6447000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3987000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4013000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4013000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4013000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4013000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32826000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33121000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33400000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 08:02:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-30096000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-30096000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,322000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,322000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-30418000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,603000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-10598000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,161000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-9834000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20584000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-25000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,45000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,20000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20564000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-818000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1792000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17954000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,24794000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6840000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-23000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6863000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32820000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1137000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1137000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,387000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,387000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,750000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1523000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3963000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3446000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2040000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1290000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1272000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1272000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1272000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1272000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32830000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 08:02:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1724000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1724000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,552000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,552000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1172000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1418000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4072000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5490000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4318000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4297000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-32000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4265000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4265000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4265000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32800000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32860000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 08:31:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2151000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2151000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,732000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,732000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1419000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,653000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1185000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1838000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-419000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-406000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-401000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2513000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2914000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2914000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32871000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32871000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32400000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:49:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2152000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2152000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,749000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,749000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1403000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-1312000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2836000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-5161000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5366000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1729000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-326000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-329000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-329000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2805000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3134000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,40000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3174000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33200000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33200000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32859000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4055000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4055000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1135000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1135000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2920000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2404000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,957000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,242000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3603000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-683000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-654000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-358000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-296000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-2439000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2735000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2735000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34200000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34200000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32912000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5291000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5291000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1482000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1482000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3809000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4157000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1132000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5289000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1480000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1455000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,358000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1813000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1944000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3756000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3756000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31300000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32958000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32958000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 06:07:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6882000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6882000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1858000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1858000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5024000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4024000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,885000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4909000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,115000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,141000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1818000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1677000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1677000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33417000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34305000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 10:33:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8080000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8080000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2181000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2181000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5899000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4706000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1978000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6684000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-785000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,334000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,334000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-451000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1326000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,875000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,46493000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,2439000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,49806000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,13000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,49793000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33300000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33307000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10054000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10054000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2212000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2212000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7842000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7235000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,670000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,552000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8457000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-615000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-126000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-126000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-741000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-130000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-611000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-754000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1365000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1365000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34148000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34148000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:00:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13290000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13290000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2924000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2924000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10366000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9377000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1055000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10432000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1232000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1232000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1298000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,130000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1428000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-457000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1885000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1885000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34264000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34264000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37700000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 08:00:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17204000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17204000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3785000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3785000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13419000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10993000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1207000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12200000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1219000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-405000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-405000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,814000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,104000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,710000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-65000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,645000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,645000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34314000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34662000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32300000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q3,2014-07-01,2014-09-30,2015-11-16 17:20:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10287000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10287000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,965000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,965000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9322000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-20042000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,36384000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,482000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16844000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7522000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7530000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7523000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-364000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,522000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7365000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,21000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7386000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34263000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21003000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21003000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4609000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4609000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16394000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12835000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1640000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,76000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14551000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1843000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,146000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,146000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1989000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,612000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1377000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1377000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1377000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34358000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34821000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34400000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 08:00:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23688000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23688000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5142000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5142000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18546000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2287000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16813000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1733000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-202000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-202000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1531000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,367000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1164000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1164000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1164000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34411000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34890000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38800000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q2,2015-04-01,2015-06-30,2015-08-10 08:00:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25331000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25331000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5390000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5390000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19941000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17325000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2306000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19631000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,310000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-790000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-132000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-658000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-658000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-658000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34444000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34444000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32900000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q3,2015-07-01,2015-09-30,2015-11-16 17:20:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9685000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9685000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11879000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11879000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-2194000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-35188000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,56627000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-1366000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15136000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35209000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37403000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-537000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-537000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37940000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-303000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,89000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37726000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34422000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.09
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34422000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.09
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.09
Osiris Therapeutics Inc,OSIR,,0001360886,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.2
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26981000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26981000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7811000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7811000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19170000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4859000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14733000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1219000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20811000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1641000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,36000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1605000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1637000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32700000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32700000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34520000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29151000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29151000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7668000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7668000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21483000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5427000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14698000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,924000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21049000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,434000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,356000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,356000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,790000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34529000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37900000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29806000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29806000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7926000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7926000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21880000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6634000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14825000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,909000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22368000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-488000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1763000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1763000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2251000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-198000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2053000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,9811000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7758000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35300000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:18:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32576000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32576000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9276000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9276000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23300000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5219000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17289000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1086000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23594000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-294000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,726000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,726000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,432000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1264000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1696000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,210000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1906000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1906000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34524000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34525000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31634000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31634000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8853000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8853000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22781000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7447000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16287000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1547000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25281000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,216000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,216000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2284000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2320000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2320000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2320000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:21:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33876000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33876000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9672000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9672000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24204000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3401000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16889000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1749000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22039000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2165000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,353000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,353000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2518000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2484000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34556000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36491000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36491000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9808000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9808000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26683000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4302000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15931000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1590000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,900000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22723000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3960000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3939000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3839000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,368000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4207000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4207000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34594000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35100000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:18:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40823000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40823000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9806000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9806000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31017000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4476000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18435000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1878000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24789000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6228000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,127000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,127000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6355000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-26175000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32530000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32530000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32530000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34526000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34573000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.95
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34500000.0
Osiris Therapeutics Inc,OSIR,,0001360886,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
